By virtue of its requirement to activate SFFV-induced Epo-independent signaling in erythroid cells and erythroleukemia in mice, sf-Stk became a likely candidate to mediate the activation of signal transduction pathways by SFFV, and subsequent studies focused on confirming this hypothesis. The gene discussed is EPO; the disease is erythroleukemia.